CDK4 and neoplasm: A comparative genomic hybridization array analysis of the primary tumor from a 27-year-old patient with relapsed and chemotherapy-refractory ARMS identified the highest level of amplification in the 12q13–14 region—more specifically, CDK4 was highly amplified in this region.